Prescription Monitoring Program Mandates and Opioids Dispensed to Patients Dying of Cancer.

ABSTRACT:

Purpose

State legislations mandating prescriber use of Prescription Drug Monitoring Programs (PDMPs) may have the unintended consequence of restricting opioid analgesics to patients dying of cancer. This study aims to assess associations of comprehensive PDMP mandates with opioid-related outcomes for patients dying of cancer, overall and by decedent race and ethnicity.

Methods

Study population were Medicare decedents who were age 66 years or older, diagnosed with breast, colorectal, lung, or prostate cancer, and died of cancer in 2011-2019. This cross-sectional study used SEER-Medicare data and a difference-in-differences design. Study sample included decedents from 10 states with an operating PDMP on January 1, 2011. Outcomes included the dichotomous event of having one or

SUBMITTER: Bao Y 

PROVIDER: S-EPMC12818174 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature